Canadian hashish producer Cover Development Corp. is suing Britain’s GW Prescription drugs in U.S. federal courtroom, alleging that GW is knowingly infringing upon Cover’s mental property.
GW makes use of a Cover-patented technique to extract the CBD that’s the energetic ingredient in its Epidiolex treatment, in line with a criticism filed Tuesday within the U.S. District Courtroom for the Western District of Texas.
The patent, U.S. Patent No. 10,870,632, covers a technique of cannabinoid extraction utilizing carbon dioxide.
Cover, based mostly in Smiths Falls, Ontario, stated it acquired the mental property when it purchased Germany’s C3 Cannabinoid Compound Co. in 2019 for greater than $250 million.
The U.S. patent was issued to Cover on Tuesday, the identical day the lawsuit was filed.
Nevertheless, Cover alleges that GW Pharma “has been monitoring the (patent) household for over fourteen years” and is conscious that its technique for manufacturing Epidiolex infringes upon Cover’s mental property.
Cover’s courtroom submitting additionally stated GW Pharma “declined a license” for a mother or father patent in 2017.
“This case will not be about proscribing affected person entry to Epidiolex,” the criticism stated.
“Somewhat, Cover brings this motion to place a cease to GW’s realizing and unauthorized use of Cover’s mental property. ”
Cover is looking for damages for GW Pharma’s alleged patent infringement in addition to enhanced damages due to the allegedly willful nature of the violation.
Epidiolex is the crown jewel of GW Pharma’s portfolio and has been authorized by regulators in a number of jurisdictions for the remedy of sure seizure problems.
U.S. gross sales of the CBD formulation comprised 87% of GW Pharma’s income for the quarter ended Sept. 30.
The UK-based firm stated in an announcement emailed to Marijuana Enterprise Day by day that it was conscious of the lawsuit.
“As a coverage, we don’t touch upon any pending litigation besides to say that based mostly on our preliminary overview of the criticism, we’re assured in our place and can vigorously defend in opposition to this lawsuit,” GW Pharma famous in its assertion.
– Solomon Israel